Emphasis on abdominal obesity as a modifier of eplerenone effect in heart failure: hypothesis-generating signals from EMPHASIS-HF

Eur J Heart Fail. 2017 Sep;19(9):1198-1200. doi: 10.1002/ejhf.884. Epub 2017 May 30.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Eplerenone
  • Heart Failure*
  • Mineralocorticoid Receptor Antagonists
  • Obesity, Abdominal*
  • Spironolactone / analogs & derivatives

Substances

  • Mineralocorticoid Receptor Antagonists
  • Spironolactone
  • Eplerenone